Guideline for Diagnosis and Management of Hepatic Hydrothorax in Cirrhosis

Diagnostic Evaluation

• Perform immediate diagnostic thoracentesis to analyze pleural fluid and exclude infection, malignancy, or cardiopulmonary causes. 1
• Serum‑to‑pleural fluid albumin gradient > 1.1 g/dL confirms hepatic hydrothorax and reflects portal hypertension. 1
• 9 % of patients with hepatic hydrothorax have no clinically apparent ascites, so absence of ascites does not rule out the condition. 1

Effusion Laterality

[1, 2]

Prognostic Considerations

• 90‑day mortality is 74 % despite a mean MELD score of 14 (which would predict 6–8 % mortality). 1
• Median survival after diagnosis is 8–12 months. 3
• Standard scores (Child‑Pugh, MELD) significantly underestimate mortality in hepatic hydrothorax. 3

First‑Line Medical Management

• Dietary sodium restriction (< 2 g/day) combined with diuretics is the cornerstone of initial therapy. 1
• Continue diuretics and salt restriction after definitive procedures until complete fluid resolution. 4

Therapeutic Thoracentesis

• Perform therapeutic thoracentesis to relieve dyspnea in symptomatic patients. 1
• Thoracentesis can be done without platelet or plasma transfusion despite coagulopathy. 1
• No evidence defines a safe upper limit of fluid volume to be removed in a single session. 1
• Rapid re‑accumulation of fluid is common, often necessitating repeated procedures. 1

Large‑Volume Paracentesis

• When ascites is present, large‑volume paracentesis with IV albumin may improve ventilatory function, but thoracentesis remains required for pleural fluid. 1

Management of Refractory Hepatic Hydrothorax

• Transjugular intrahepatic portosystemic shunt (TIPS) or liver transplantation are the preferred options for refractory or recurrent disease. 1

TIPS

• Consider TIPS as second‑line therapy in carefully selected patients. 1
• Complete response occurs in ≈ 56 % of cases; TIPS can be definitive or a bridge to transplantation. 3
• Use small‑diameter PTFE‑covered stents to lower the risk of shunt dysfunction and hepatic encephalopathy. 4

TIPS Contraindications

[4, 3, 5]

Liver Transplantation

• All patients with hepatic hydrothorax should be evaluated for transplantation because of the extremely poor prognosis. 1
• Transplantation is the only definitive curative therapy. 3

Procedures to Avoid

• Chest tube insertion is discouraged due to high rates of protein loss, malnutrition, pleural infection, and septic shock. 1
• Chemical pleurodesis is not recommended; it often leads to loculated collections. 1

[3]

Alternative Options for Select Patients

• Indwelling tunneled pleural catheters may be used in patients who fail medical therapy and are not candidates for TIPS or transplantation, acknowledging the risk of protein depletion and malnutrition. 1

Key Clinical Pitfalls (What Not to Do)

• Do not target serum albumin levels with albumin infusions outside the specific indication of spontaneous bacterial empyema.
• Do not place chest tubes for chronic drainage in hepatic hydrothorax. 1
• Do not delay transplant evaluation based solely on MELD score, as mortality far exceeds MELD predictions. 1
• Do not assume absence of ascites excludes hepatic hydrothorax, given that 9 % occur without visible ascites. 1

Right-Sided Hydrothorax Diagnosis and Management

Primary Hepatic Causes

• The American Association for the Study of Liver Diseases suggests that hepatic hydrothorax should be the first consideration for right-sided pleural effusion, particularly when serum urea is elevated, indicating renal dysfunction from hepatorenal physiology 6
• The pleural fluid in hepatic hydrothorax originates from peritoneal ascites migrating through small diaphragmatic defects driven by negative intrathoracic pressure during inspiration 6
• Critically, 9% of patients with hepatic hydrothorax have no clinically apparent ascites, making diagnosis challenging when obvious abdominal fluid is not present 6
• A serum-to-pleural fluid albumin gradient >1.1 g/dL strongly confirms hepatic hydrothorax, according to the American College of Gastroenterology 6
• Patients with hepatic hydrothorax have a poor prognosis, with 74% mortality at 90 days despite relatively low MELD scores, as reported by the American Association for the Study of Liver Diseases 6
• Right-sided predominance occurs in approximately 88% of hepatic hydrothorax cases, as noted by the European Association for the Study of the Liver 7

Infectious Complications

• The Infectious Diseases Society of America recommends that spontaneous bacterial empyema (SBE) must be excluded in any cirrhotic patient with hydrothorax, as it occurs in 50% of cases alongside spontaneous bacterial peritonitis 8, 6
• SBE is diagnosed when pleural fluid absolute neutrophil count exceeds 250/mm³, similar to SBP criteria, according to the American Thoracic Society 8, 6
• Pleural fluid culture in blood culture bottles is positive in 75% of SBE cases, as reported by the Journal of Hepatology 8

Malignant Causes

• A serum-to-pleural fluid albumin gradient ≤1.1 g/dL, left-sided effusion, or absence of ascites should raise suspicion for malignancy rather than hepatic hydrothorax, according to the National Comprehensive Cancer Network 6
• Lung cancer, breast cancer, and lymphoma are the most common primary tumors causing combined ascites and pleural effusion, as noted by the American Cancer Society 6

Cardiac Causes

• The European Society of Cardiology suggests that bilateral pleural effusions with ascites in the setting of cardiomegaly on chest radiograph strongly suggests cardiac etiology rather than hepatic hydrothorax 6
• Right-sided heart failure can cause right-sided predominant effusions with elevated BUN from cardiorenal syndrome, as reported by the European Heart Journal 9, 10

Diagnostic Algorithm

• The American College of Chest Physicians recommends performing diagnostic paracentesis with cell count, differential, total protein, LDH, glucose, pH, and culture immediately in any hospitalized patient with ascites, even without symptoms 6
• Calculate serum-to-pleural fluid albumin gradient: gradient >1.1 g/dL indicates portal hypertension-related hydrothorax, while gradient ≤1.1 g/dL suggests malignancy, infection, or other non-portal hypertension causes, according to the American Association for the Study of Liver Diseases 6